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1. Introduction 
Epidemiologic and experimental evidence indicate that oral cancer originates and 
progresses with the contribution of carcinogen exposure, mainly from tobacco smoking 
(IARC, 1986, 2004). This is thought to contribute to DNA damage within the mucosa and, in 
particular, to subsequent gene mutations, chromosomal instability and aneuploidy, 
resulting in an increased risk of developing oral cancer. Accumulation of genetic/genomic 
aberrations over time leads to a multi-step process of carcinogenesis in which the functions 
of genes which control the cell cycle (proliferation and apoptosis), chromosome stability, 
angiogenesis, invasion and metastasis, become aberrant (Califano et al., 1996; Hanahan & 
Weinberg 2011; Martorell-Calatayud et al., 2009). Chromosomal aberrations in oral cancer 
are located, in particular, at 9p21, 17p13, 3q26, 11q13, 3p21, 14q32 (Forastiere et al., 2001; 
Gollin, 2001) corresponding to several putative tumor suppressor genes and oncogenes 
including p16 at 9p21 and TP53 at 17p13. 
Studies aimed at elucidating the steps of transition between the oral precursor lesions and 
oral cancer and, in particular, the transition from visually normal appearing non-dysplastic 
oral mucosa to  precursor lesions are potentially very informative. Such investigations 
address the theory of “field cancerization” (Slaughter et al., 1953) and its more recent genetic 
explanation (Braakhuis et al., 2003; Tabor et al., 2001). These studies have led to a genetic 
progression model of oral cancer (Braakhuis et al., 2004). A critical step in this model is the 
conversion of a patch, in which stem cells share genetic/genomic aberrations, into an 
expanding field in which many more aberrations occur and which sometimes becomes 
visible as leukoplakias and erythroplakias (Braakhuis et al., 2002; Reid et al., 1997; Van 
Houten et al., 2000).  The role of chromosomal instability during the genesis and progression 
of oral cancer has clearly been indicated by several studies but still our understanding of the 
molecular mechanisms is relatively poor. Analyses were performed with the use of different 
techniques including loss of heterozygosity (Braakhuis et al., 2004; Bremmer et al., 2008; 
Graveland et al., 2011; Lydiatt et al., 1998; Mithani et al., 2007; Partridge et al., 1997; 
Tsantoulis et al., 2007), comparative genomic hybridization and gene expression array 
(Bremmer et al., 2008; Cha et al., 2011; Garnis et al., 2009; Liu et al., 2006, 2011; Smeets et al., 
2009; Snijders et al., 2005; Squire et al., 2002;), in situ hybridization (Nees et al., 1993; 
Voravud et al., 1993), immunohistochemistry (Nees et al., 1993), multiplex ligation-
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dependent probe amplification (Bremmer et al., 2008; Cha et al., 2011; Liu et al., 2006), DNA 
image cytometry (Bremmer et al., 2008; Diwakar et al., 2005) and DNA flow cytometry 
(DNA FCM) (Donadini et al., 2010; Hemmer, 1990, 1997; Pentenero et al., 2009; Saito, 1998, 
1991, 1995; Seoane  et al., 1998). DNA FCM was often adopted as a useful technique for 
detecting the presence of DNA aneuploid sublines in several human predisposing and 
preneoplastic lesions such as Barrett’s esophagus (Reid et al., 2000), ulcerative colitis 
(Rabinovitch et al., 1999; Risques et al., 2008), colorectal adenomas  (Giaretti et al., 1994) and 
oral lesions (Donadini et al., 2010; Pentenero et al., 2009; Saito, 1998, 1991, 1995; Seoane et al., 
1998). 
2. High resolution DNA FCM of oral lesions and visually normal  
non-dysplastic mucosa 
The DNA FCM data provided so far for the human oral precancerous lesions were mainly 
derived from paraffin-embedded material of dysplastic oral potentially malignant lesions 
(OPMLs). In order to better investigate early oral fields of carcinogenesis and to separate 
them from later progression steps, we have included the analysis of non-dysplastic “oral 
clinically normal appearing mucosa sited in OPML and OSCC distant fields within the same 
subsites” (ODFs; n = 122). In addition, we have analyzed multiple samples from OPMLs 
without and with dysplasia at histology, including also the lesion margins. OPMLs in our 
series of cases were clinically identified mainly as white lesions of the oral mucosa or 
leukoplakias (n = 235). Further, we analyzed, though in a relatively small number of cases, 
oral verrucous carcinomas (OVCs; n = 9) and oral squamous cell carcinomas (OSCCs; n = 
32). In all cases the multiple samples were only from fresh/frozen material. Patients were 
recruited in three different medical centers: the Oral Medicine and Oral Oncology Section of 
the University of Turin, the Department of Otolaryngology, “S. Martino Hospital” in Genoa 
and the National Institute for Cancer Research in Genoa. Patient written consent was 
obtained in every case according to the Institutional Ethic Committees. Diagnosis in every 
case was obtained from the Pathology Departments of the same Institutions. In particular, 
the diagnosis of OPMLs, using both incisional biopsies and/or microbiopsies as previously 
detailed (Navone et al., 2008) was based on internationally accepted criteria with levels of 
diagnostic certainty C3-C4 (Van der Waal et al., 2009). The assessment of the degree of 
dysplasia was carried out by a specially trained pathologist according to the WHO 
guidelines (IARC, 2005). Tissue fragments were minced on Petri dishes using scalpels and 
collected in 2 ml detergent solution (0.1 M citric acid, 0.5% Tween-20) (Otto, 1994) and then 
submitted to mechanical disaggregation in a disposable 50 m Medicon using a 
Medimachine (DAKO, Copenhagen, Denmark). Nuclei suspensions were obtained and 
filtered over a 50 m nylon sieve (CellTrics, Partec GmbH, Muenster, Germany). An 
absolute count of the nuclei in suspension was performed by FCM (CyFlow® ML, Partec 
GmbH (Shapiro, 2003)) after 1 to 10 dilution in water. The final volume was calculated to 
obtain the concentration of 600,000 nuclei/ml. One volume (1/7 of the final volume) of 
detergent solution was first added followed by 10 min incubation and gentle shaking. 
Finally, 6 volumes (6/7 of the final volume) of staining solution (0.4 M Na2HPO4, 5 M 
DAPI in water) were added. Samples were kept on dark for a minimum of 15 min 
incubation before filtering and FCM analysis. Excitation of DAPI was provided with an UV 
mercury lamp (HBO-100 W, Partec GmbH) and the emitted blue fluorescence was collected 
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using a 435 nm long-pass filter. Measurements of DNA content histograms were performed 
with a high resolution DNA FCM (CyFlow® ML,  PartecGmbH (Shapiro, 2003)) according 
to quality controls and analysis consensus criteria (Ormerod et al., 1998). Only samples with 
at least 2 separate G0–G1 peaks were considered DNA aneuploid. Sex specific human 
lymphocytes and “true oral normal mucosa” from healthy donors were used as DNA 
diploid controls. DNA Index (DI) values were evaluated as the ratio of the mean channel 
number of the DNA aneuploid G0–G1 peak to the mean channel number of the DNA 
diploid G0–G1 peak. Thus, DNA diploid and aneuploid sublines have values respectively 
DI =1 and DI ≠ 1. The CV values of the G0–G1 peaks for the DNA diploid normal mucosa 
samples from healthy donors were used as a measure of accuracy (DNA resolution): a 
mean CV= 1.88±0.26% was obtained by a Gaussian curve fitting method (FloMax Software 
3.0b4 2001, Partec GmbH). The mean CV value using human lymphocytes from sex 
specific healthy donors was 1.2 ± 0.2%. Data collection, management and analyses were 
done using Microsoft Office Excel and the SPSS 16.0 software package (Apache Software 
Foundation, Chicago, IL, USA). The association between two variables in 2 x 2 
contingency tables was evaluated with the Fisher exact test. A p-value < 0.05 was taken as 
statistically significant.  
Table 1a shows the prevalence of DNA aneuploidy for 7 subgroups of oral mucosa/lesions: 
“true normal mucosa” from healthy donors (n = 36), non-dysplastic ODFs corresponding to 
OPMLs (n = 105), and OPMLs without (n = 208) and with dysplasia (n=27) were DNA 
aneuploid respectively in none of the cases, in 12/105 (11.4%), 37/208 (17.8%) and in 10/27 
(37%).  The samples relative to advanced cancer, respectively OVCs and OSCCs, were DNA 
aneuploid in 6/9 (66.7%) and 25/32 (78.1%) cases. ODFs corresponding to OSCCs were 
DNA aneuploid in 3/17 (17.6%) cases. Two or more DNA aneuploid sublines were detected 
in none of the ODFs, in 5/37 (13.5%) of the OPMLs without dysplasia, in 2/10 (20%) of the 
OPMLs with dysplasia. OVCs and OSCCs presented respectively multiple DNA aneuploid 
sublines in 2/6 (33.3%) and in 13/25 (52%) cases. 
 
Oral mucosa/lesion groups 
N. cases 
within 
groups 
N. DNA 
aneuploid  
cases 
One DNA 
aneuploid  
subline 
Two or more  
DNA 
aneuploid 
sublines 
"True normal mucosa"         
from healthy donors  
36 0 (0%) - - 
ODFs corresponding to OPMLs 105 12 (11.4%) 12 (100%) 0 (0%) 
OPMLs without dysplasia 208 37 (17.8%) 32 (86.5%) 5 (13.5%) 
OPMLs with dysplasia 27 10 (37.0%) 8 (80.0%) 2 (20.0%) 
OVCs 9 6 (66.7%) 4 (66.7%) 2 (33.3%) 
ODFs corresponding to OSCCs 17 3 (17.6%) 3 (100%) 0 (0%) 
OSCCs 32 25 (78.1%) 12 (48.0%) 13 (52.0%) 
Abbreviations: ODFs = non-dysplastic oral clinically normal appearing mucosa sited in OPML and 
OSCC distant fields within the same anatomical subsites; OPMLs = Oral Potentially Malignant Lesions 
(mainly leukoplakias); OVCs = Oral Verrucous Carcinomas; OSCCs = Oral Squamous Cell Carcinomas. 
Table 1a. DNA aneuploidy by high resolution DNA FCM among 7 different groups of oral 
lesions and non-dysplastic normal appearing mucosa. The last 2 columns report the cases 
with single and multiple DNA aneuploid sublines.  
www.intechopen.com
 
Oral Cancer 
 
330 
All the DI aneuploid sublines (n = 126) were subdivided in 2 classes: DNA near-diploid  
(DI ≠ 1 and <1.4) and DNA high aneuploid (DI ≥1.4) (Table 1b). ODFs and OPMLs without 
dysplasia were characterized by near-diploid sublines respectively in 12/12 (100%) and in 
38/43 (88.4%) of the cases. OVCs had a significantly higher frequency of DNA near-diploid 
aneuploid cases than OSCCs (respectively, 87.5% and 33.3%; p=0.006). In contrast, OPMLs 
with dysplasia and OSCCs had high aneuploid sublines respectively in 5 out of 12 (41.7%) 
and in 32 out of 48 (66.7%) of the cases. The prevalence of high aneuploidy in OPMLs with 
dysplasia was statistically significantly higher than in OPMLs without dysplasia (p = 0.03).  
 
Oral mucosa/lesion groups 
N. DNA 
aneuploid 
sublines 
N. DNA near-diploid 
aneuploid sublines 
(DI≠1 and DI<1.4) 
N. DNA high aneuploid 
sublines (DI≥1.4) 
"True normal mucosa"       
from healthy donors  
- - - 
ODFs corresponding to OPMLs 12 12 (100%) 0 (0%) 
OPMLs without dysplasia 43 38 (88.4%) 5 (11.6%) 
OPMLs with dysplasia 12 7 (58.3%) 5 (41.7%) 
OVCs 8 7 (87.5%) 1 (12.5%) 
ODFs corresponding to OSCCs 3 2 (66.7%) 1 (33.3%) 
OSCCs 48 16 (33.3%) 32 (66.7%) 
Abbreviations: ODFs = non-dysplastic oral clinically normal appearing mucosa sited in OPML and 
OSCC distant fields within the same anatomical subsites; OPMLs = Oral Potentially Malignant Lesions 
(mainly leukoplakias); OVCs = Oral Verrucous Carcinomas; OSCCs = Oral Squamous Cell Carcinomas. 
Table 1b. Presence of DNA near-diploid (DI≠1 and DI<1.4) and high aneuploid (DI≥1.4) 
sublines among 7 different groups of oral mucosa/lesions. DNA aneuploidy was measured 
by high resolution DNA FCM.  
3. Discussion 
The incidence of DNA aneuploidy by FCM reported in the literature ranges from about 10% 
to 40% for dysplastic OPMLs (Donadini et al. 2010; Pentenero et al. 2009; Saito et al., 1998, 
1991, 1995; Seoane et al., 1998) and up to about 80% for OSCCs (Donadini et al., 2010; 
Pentenero et al. 2009; Hemmer, 1990, 1997). These values may strongly depend on the tissue 
material type (paraffin embedded or fresh–frozen) and DNA FCM resolution. In the present 
study, partly based on a previous data set that was already published (Donadini et al., 2010), 
we have performed FCM measurements at optimized conditions (fresh–frozen material, 
concentration of 600,000 nuclei/ml, DAPI staining in nuclei suspensions, UV incident light, 
the use of a dedicated instrument). Correspondingly, the CV values of the G0–G1 peaks of 
human normal control DNA diploid nuclei were commonly near 1%, while a minimum 
DNA change of 2.4% was detected (Figure 1). It is likely that DNA FCM at lower resolution 
and higher CV values would not allow  separating DNA near-diploid aneuploid sublines 
with only slight DNA changes above/below DNA diploidy.  
The present data set confirmed in a larger number of cases that, while “true normal oral 
mucosa” and human lymphocytes of healthy donors were DNA diploid in all cases, non-
dysplastic “clinically normal appearing mucosa fields of the oral cavity” (ODFs) in patients 
with OPMLs already contained DNA aneuploid sublines in a subgroup of cases (12/105, 11%). 
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Moreover, it was found that OPMLs that could be clinically identified mainly as white lesions 
of the oral mucosa (leukoplakias) and classified without dysplasia at histology, contained 
already DNA aneuploid sublines in 37/208 (18%) of the cases. These data appear in agreement 
with the concept of field effect in oral carcinogenesis (Braakhuis et al., 2003; Bremmer et al., 
2008; Leemans, 2011; Tabor et al., 2001; Van der Waal, 1997). The data obtained for the non-
dysplastic OPMLs, in particular, were in agreement with previous literature reports including 
two studies from our group using an independent patient population (Donadini et al., 2010; 
Pentenero et al., 2009; Saito, 1995). These data were, however, in contrast with other studies, 
which did not detect DNA aneuploid sublines in such lesions (Kahn et al., 1992; Saito, 1998). 
The present study has additionally highlighted that ODFs and OPMLs without dysplasia were 
characterized by single near-diploid DNA aneuploid sublines. On the contrary, OPMLs with 
dysplasia contained high DNA aneuploid sublines (DI ≥1.4) in slightly less than half of the 
cases (42%). High DNA aneuploid sublines were predominant (67%) for the OSCCs, which 
were in addition characterized by the presence of multiple DNA aneuploid sublines in 52% of 
the DNA aneuploid cases. In contrast, OVCs were characterized by DNA near-diploid 
aneuploid sublines in 67% of the cases in agreement with previously published data 
(Pentenero et al., 2011).  Overall, the present data support a previous model of aneuploidy 
genesis and evolution (Giaretti, 1994). Accordingly, a transition from DNA diploidy to near-
diploid aneuploidy would be an early step of the natural history of OPMLs, while high DNA 
aneuploidy (likely to derive from the endoreduplication of a DNA hypo-diploid or hyper-
diploid near-diploid cell) would frequently occur as a later event in OPMLs with dysplasia 
and OSCCs (Figure 1). From the clinical point of view, one can speculate that the detection of 
DNA content genomic aberrations in oral fields, which appear visually and histologically 
normal, and in OPMLs may have profound implications for improvement of the present 
patient management by identifying individuals at high risk to develop cancer (Brennan et al., 
2007; Dakubo et al., 2007; Lodi et al., 2006). 
Moreover, it is possible, though still unproved, that the OSCC group in which near-diploid 
aneuploid DIs remained “frozen” during time are at better prognosis compared to OSCCs 
with multiple DNA aneuploid sublines with high DNA aneuploidy. Interestingly, OVCs 
that were mainly characterized by DI values in the near-diploid region are known to be less 
aggressive and at better prognosis than OSCCs.  
Clearly, what is still strongly needed in the model system of oral preneoplasia and neoplasia 
is a better understanding of the origin and dynamic evolution of chromosomal instability, 
chromosomal aberrations and aneuploidy (Albertson et al., 2003; Asteriti et al., 2010; 
Compton et al., 2011; Geigl et al., 2008; Giet et al., 2005; Kops et al., 2005; Lingen et al., 2011; 
Sieber et al., 2003; Suijkerbuijk & Kops, 2008; Thompson et al., 2010; Viet & Schmidt, 2010). 
In other models of cancer genesis and progression, like the colorectal adenoma-carcinoma 
sequence, the Barrett's esophagus and the ulcerative colitis transition to carcinoma, the role 
of APC and TP53 has been highlighted (Fodde et al., 2001; Giaretti et al., 2004; Rabinovitch 
et al., 2004). A role of TP53 in oral cancer chromosomal instability (Negrini et al., 2010) is 
also likely to occur due to different sources of TP53 inactivation including HPV infection in 
different sites of the oral cavity (Leemans, 2011; Klingelhutz et al., 2005; Tsantoulis et al., 
2007). Studies that linked the genome-wide integrity analysis with gene expression profiles 
have provided powerful indications that chromosomal instability and aneuploidy massively 
deregulate the cellular transcriptome (Albertson et al., 2003). Future studies coupling both 
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these techniques are likely to contribute to discover specific recurrent genomic aberrations, 
which encompass specific genes with a potential role in the genesis of chromosomal 
instability and aneuploidy. The functional consequences of specific DNA gains/losses are, 
however, not only involving oncogenes and tumor suppressor genes. More subtle and 
complex mechanisms are present since many aberrations span large chromosomal regions 
including normal genes, which coordinately and cooperatively may influence important cell 
functions as proliferation, differentiation, apoptosis and DNA repair.  
 
 
Fig. 1. Examples of DNA content histograms from oral fresh/frozen mucosa/lesions as 
obtained by low background and high resolution DNA FCM. A model of DNA 
aneuploidization and evolution.  
Single DNA aneuploid sublines in the DNA near-diploid aneuploid region (DI1 and 
DI<1.4) are shown in A and B for two OPMLs. Sex specific human lymphocytes (Ly) and 
true normal mucosa of healthy donors were used as DNA diploid controls (DI=1.0). 
Multiple DNA aneuploid sublines for an OSCC with DI values respectively of 1.12 and 2.18 
are shown in C. This example illustrates a model of DNA aneuploidisation as previously 
reported (Giaretti, 1994; Donadini et al., 2010). The key mechanism of DNA 
aneuploidisation appears related to a loss of symmetry of DNA content during an abnormal 
mitotic division in which the two daughter cells loose or gain respectively a small amount of 
DNA and generate DNA near-diploid aneuploid sublines (see examples A and B). A second 
www.intechopen.com
 
Model of Chromosomal Instability in Oral Carcinogenesis and Progression 
 
333 
step of DNA aneuploidy evolution appears to be due to the endoreduplication of the DNA 
near-diploid aneuploid cells sublines (see example C). The large G0-G1 subpopulation of 
cells with DI= 2.18 is characterized by a relatively large CV value (about 3% with respect to 
2% of the G0-G1 DNA diploid peak), which is indicative of chromosomal instability and 
potential loss of DNA. The DI= 2.18 value of the high DNA aneuploid G0-G1 peak was 
likely originated from an initial DI value of 2.24 (twice as much of the original near-diploid 
DI=1.12 ) with the loss of 2.7% DNA. 
An example of DNA histogram with a small G0-G1 DNA aneuploid peak (with 5% of the 
total number of nuclei in this case) and with DI= 1.24 is shown in D to illustrate that such a 
small percentage of DNA aneuploid nuclei can be sufficient to be detected by our high 
resolution and low background DNA FCM measurements. This approach was characterized 
by the use of fresh/frozen tissue material, nuclei suspensions at the fixed concentration of 
600,000 nuclei/ml, DAPI staining and a dedicated FCM instrument (see details in the text; 
Donadini et al., 2010; Shapiro, 2003). 
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